+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Conjugate Vaccine Market Research Report by Type, Indication, Pathogen Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 234 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 4896495
UP TO OFF until Dec 31st 2022
The Global Conjugate Vaccine Market size was estimated at USD 32.43 billion in 2021, USD 35.84 billion in 2022, and is projected to grow at a CAGR of 10.71% to reach USD 59.72 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Conjugate Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Monovalent and Multivalent.
  • Based on Indication, the market was studied across Diphtheria and Pertussis, Influenza, Meningococcal, and Pneumococcal.
  • Based on Pathogen Type, the market was studied across Bacterial Conjugate Vaccine, Combination Conjugate Vaccine, and Viral Conjugate Vaccine.
  • Based on End User, the market was studied across Adults Conjugate Vaccine and Pediatrics Conjugate Vaccine.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Conjugate Vaccine market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Conjugate Vaccine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Conjugate Vaccine Market, including Bharat Biotech, Biological E. Ltd, CSL Limited, GlaxoSmithKline, plc., Merck and Company, Novartis AG, Nuron Biotech Inc., Pfizer, Inc., Sanofi Pasteur, and Serum Institute of India.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Conjugate Vaccine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Conjugate Vaccine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Conjugate Vaccine Market?
4. What is the competitive strategic window for opportunities in the Global Conjugate Vaccine Market?
5. What are the technology trends and regulatory frameworks in the Global Conjugate Vaccine Market?
6. What is the market share of the leading vendors in the Global Conjugate Vaccine Market?
7. What modes and strategic moves are considered suitable for entering the Global Conjugate Vaccine Market?
Frequently Asked Questions about the Global Conjugate Vaccine Market

What is the estimated value of the Global Conjugate Vaccine Market?

The Global Conjugate Vaccine Market was estimated to be valued at $32.43 Billion in 2021.

What is the growth rate of the Global Conjugate Vaccine Market?

The growth rate of the Global Conjugate Vaccine Market is 10.7%, with an estimated value of $59.72 Billion by 2027.

What is the forecasted size of the Global Conjugate Vaccine Market?

The Global Conjugate Vaccine Market is estimated to be worth $59.72 Billion by 2027.

Who are the key companies in the Global Conjugate Vaccine Market?

Key companies in the Global Conjugate Vaccine Market include Bharat Biotech, Biological E. Ltd, CSL Limited, GlaxoSmithKline, plc., Merck and Company, Novartis AG, Nuron Biotech Inc., Pfizer, Inc. and Serum Institute of India.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of infectious diseases
5.1.1.2. Rising adoption of cancer therapeutic vaccines
5.1.1.3. Rising number programs to promote vaccination by WHO
5.1.2. Restraints
5.1.2.1. Low accessibility to vaccines in remote areas
5.1.3. Opportunities
5.1.3.1. Government initiatives for infectious diseases
5.1.3.2. Advancement in technology of emergin pathogens
5.1.4. Challenges
5.1.4.1. Complexity of production procedure of conjugate vaccine
5.2. Cumulative Impact of COVID-19
6. Conjugate Vaccine Market, by Type
6.1. Introduction
6.2. Monovalent
6.3. Multivalent
7. Conjugate Vaccine Market, by Indication
7.1. Introduction
7.2. Diphtheria and Pertussis
7.3. Influenza
7.4. Meningococcal
7.5. Pneumococcal
8. Conjugate Vaccine Market, by Pathogen Type
8.1. Introduction
8.2. Bacterial Conjugate Vaccine
8.3. Combination Conjugate Vaccine
8.4. Viral Conjugate Vaccine
9. Conjugate Vaccine Market, by End User
9.1. Introduction
9.2. Adults Conjugate Vaccine
9.3. Pediatrics Conjugate Vaccine
10. Americas Conjugate Vaccine Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Conjugate Vaccine Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Conjugate Vaccine Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Bharat Biotech
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Biological E. Ltd
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. CSL Limited
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. GlaxoSmithKline, plc.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Merck and Company
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Novartis AG
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Nuron Biotech Inc.
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Pfizer, Inc.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Sanofi Pasteur
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Serum Institute of India
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL CONJUGATE VACCINE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CONJUGATE VACCINE MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 4. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. GLOBAL CONJUGATE VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL CONJUGATE VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL CONJUGATE VACCINE MARKET DYNAMICS
FIGURE 11. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL CONJUGATE VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2027
FIGURE 14. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MONOVALENT, 2018-2027 (USD BILLION)
FIGURE 15. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MULTIVALENT, 2018-2027 (USD BILLION)
FIGURE 16. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2021 VS 2027 (%)
FIGURE 17. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2021 VS 2027 (USD BILLION)
FIGURE 18. GLOBAL CONJUGATE VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY INDICATION, 2027
FIGURE 19. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DIPHTHERIA AND PERTUSSIS, 2018-2027 (USD BILLION)
FIGURE 20. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INFLUENZA, 2018-2027 (USD BILLION)
FIGURE 21. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MENINGOCOCCAL, 2018-2027 (USD BILLION)
FIGURE 22. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PNEUMOCOCCAL, 2018-2027 (USD BILLION)
FIGURE 23. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2021 VS 2027 (%)
FIGURE 24. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 25. GLOBAL CONJUGATE VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY PATHOGEN TYPE, 2027
FIGURE 26. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY BACTERIAL CONJUGATE VACCINE, 2018-2027 (USD BILLION)
FIGURE 27. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY COMBINATION CONJUGATE VACCINE, 2018-2027 (USD BILLION)
FIGURE 28. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY VIRAL CONJUGATE VACCINE, 2018-2027 (USD BILLION)
FIGURE 29. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 30. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2021 VS 2027 (USD BILLION)
FIGURE 31. GLOBAL CONJUGATE VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2027
FIGURE 32. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY ADULTS CONJUGATE VACCINE, 2018-2027 (USD BILLION)
FIGURE 33. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PEDIATRICS CONJUGATE VACCINE, 2018-2027 (USD BILLION)
FIGURE 34. AMERICAS CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 35. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 36. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 37. AMERICAS CONJUGATE VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 38. ARGENTINA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 39. BRAZIL CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 40. CANADA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 41. MEXICO CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 42. UNITED STATES CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 43. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 44. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 45. UNITED STATES CONJUGATE VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 46. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 47. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 48. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 49. ASIA-PACIFIC CONJUGATE VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 50. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 51. CHINA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 52. INDIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 53. INDONESIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 54. JAPAN CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 55. MALAYSIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 56. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 57. SINGAPORE CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 58. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 59. TAIWAN CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 60. THAILAND CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 61. VIETNAM CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 62. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 66. DENMARK CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 67. EGYPT CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 68. FINLAND CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 69. FRANCE CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 70. GERMANY CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 71. ISRAEL CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 72. ITALY CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 73. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 74. NIGERIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 75. NORWAY CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 76. POLAND CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 77. QATAR CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 78. RUSSIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 79. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 80. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 81. SPAIN CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 82. SWEDEN CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 83. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 84. TURKEY CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 85. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 86. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 87. GLOBAL CONJUGATE VACCINE MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 88. GLOBAL CONJUGATE VACCINE MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 89. GLOBAL CONJUGATE VACCINE MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL CONJUGATE VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MONOVALENT, 2018-2027 (USD BILLION)
TABLE 8. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MONOVALENT, BY REGION, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MONOVALENT, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MULTIVALENT, 2018-2027 (USD BILLION)
TABLE 11. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MULTIVALENT, BY REGION, 2018-2027 (USD BILLION)
TABLE 12. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MULTIVALENT, BY REGION, 2018-2027 (USD BILLION)
TABLE 13. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 14. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DIPHTHERIA AND PERTUSSIS, 2018-2027 (USD BILLION)
TABLE 15. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DIPHTHERIA AND PERTUSSIS, BY REGION, 2018-2027 (USD BILLION)
TABLE 16. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DIPHTHERIA AND PERTUSSIS, BY REGION, 2018-2027 (USD BILLION)
TABLE 17. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INFLUENZA, 2018-2027 (USD BILLION)
TABLE 18. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2027 (USD BILLION)
TABLE 19. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2027 (USD BILLION)
TABLE 20. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MENINGOCOCCAL, 2018-2027 (USD BILLION)
TABLE 21. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MENINGOCOCCAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 22. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MENINGOCOCCAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 23. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PNEUMOCOCCAL, 2018-2027 (USD BILLION)
TABLE 24. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PNEUMOCOCCAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 25. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PNEUMOCOCCAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 26. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 27. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY BACTERIAL CONJUGATE VACCINE, 2018-2027 (USD BILLION)
TABLE 28. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY BACTERIAL CONJUGATE VACCINE, BY REGION, 2018-2027 (USD BILLION)
TABLE 29. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY BACTERIAL CONJUGATE VACCINE, BY REGION, 2018-2027 (USD BILLION)
TABLE 30. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY COMBINATION CONJUGATE VACCINE, 2018-2027 (USD BILLION)
TABLE 31. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY COMBINATION CONJUGATE VACCINE, BY REGION, 2018-2027 (USD BILLION)
TABLE 32. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY COMBINATION CONJUGATE VACCINE, BY REGION, 2018-2027 (USD BILLION)
TABLE 33. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY VIRAL CONJUGATE VACCINE, 2018-2027 (USD BILLION)
TABLE 34. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY VIRAL CONJUGATE VACCINE, BY REGION, 2018-2027 (USD BILLION)
TABLE 35. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY VIRAL CONJUGATE VACCINE, BY REGION, 2018-2027 (USD BILLION)
TABLE 36. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 37. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY ADULTS CONJUGATE VACCINE, 2018-2027 (USD BILLION)
TABLE 38. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY ADULTS CONJUGATE VACCINE, BY REGION, 2018-2027 (USD BILLION)
TABLE 39. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY ADULTS CONJUGATE VACCINE, BY REGION, 2018-2027 (USD BILLION)
TABLE 40. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PEDIATRICS CONJUGATE VACCINE, 2018-2027 (USD BILLION)
TABLE 41. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PEDIATRICS CONJUGATE VACCINE, BY REGION, 2018-2027 (USD BILLION)
TABLE 42. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PEDIATRICS CONJUGATE VACCINE, BY REGION, 2018-2027 (USD BILLION)
TABLE 43. AMERICAS CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 44. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 45. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 46. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 47. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 48. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 49. ARGENTINA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 50. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 51. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 52. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 53. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 54. BRAZIL CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 55. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 56. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 57. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 58. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 59. CANADA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 60. CANADA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 61. CANADA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 62. CANADA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 63. CANADA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 64. MEXICO CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 65. MEXICO CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 66. MEXICO CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 67. MEXICO CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 68. MEXICO CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 69. UNITED STATES CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 70. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY STATE, 2018-2027 (USD BILLION)
TABLE 71. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 72. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 73. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 74. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 75. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 76. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 77. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 78. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 79. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 80. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 81. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 82. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 83. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 84. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 85. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 86. CHINA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 87. CHINA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 88. CHINA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 89. CHINA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 90. CHINA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 91. INDIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 92. INDIA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 93. INDIA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 94. INDIA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 95. INDIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 96. INDONESIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 97. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 98. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 99. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 100. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 101. JAPAN CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 102. JAPAN CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 103. JAPAN CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 104. JAPAN CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 105. JAPAN CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 106. MALAYSIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 107. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 108. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 109. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 110. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 111. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 112. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 113. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 114. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 115. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 116. SINGAPORE CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 117. SINGAPORE CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 118. SINGAPORE CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 119. SINGAPORE CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 120. SINGAPORE CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 121. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 122. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 123. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 124. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 125. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 126. TAIWAN CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 127. TAIWAN CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 128. TAIWAN CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 129. TAIWAN CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 130. TAIWAN CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 131. THAILAND CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 132. THAILAND CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 133. THAILAND CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 134. THAILAND CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 135. THAILAND CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 136. VIETNAM CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 137. VIETNAM CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 138. VIETNAM CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 139. VIETNAM CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 140. VIETNAM CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 147. DENMARK CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 148. DENMARK CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 149. DENMARK CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 150. DENMARK CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 151. DENMARK CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 152. EGYPT CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 153. EGYPT CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 154. EGYPT CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 155. EGYPT CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 156. EGYPT CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 157. FINLAND CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 158. FINLAND CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 159. FINLAND CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 160. FINLAND CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 161. FINLAND CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 162. FRANCE CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 163. FRANCE CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 164. FRANCE CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 165. FRANCE CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 166. FRANCE CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 167. GERMANY CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 168. GERMANY CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 169. GERMANY CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 170. GERMANY CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 171. GERMANY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 172. ISRAEL CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 173. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 174. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 175. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 176. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 177. ITALY CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 178. ITALY CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 179. ITALY CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 180. ITALY CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 181. ITALY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 182. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 183. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 184. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 185. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 186. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 187. NIGERIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 188. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 189. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 190. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 191. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 192. NORWAY CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 193. NORWAY CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 194. NORWAY CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 195. NORWAY CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 196. NORWAY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 197. POLAND CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 198. POLAND CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 199. POLAND CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 200. POLAND CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 201. POLAND CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 202. QATAR CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 203. QATAR CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 204. QATAR CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 205. QATAR CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 206. QATAR CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 207. RUSSIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 208. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 209. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 210. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 211. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 212. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 213. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 214. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 215. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 216. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 217. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 218. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 219. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 220. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 221. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 222. SPAIN CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 223. SPAIN CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 224. SPAIN CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 225. SPAIN CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 226. SPAIN CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 227. SWEDEN CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 228. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 229. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 230. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 231. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 232. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 233. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 234. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 235. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 236. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 237. TURKEY CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 238. TURKEY CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 239. TURKEY CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 240. TURKEY CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 241. TURKEY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 242. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 243. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 244. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 245. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 246. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 247. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 248. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2027 (USD BILLION)
TABLE 249. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2027 (USD BILLION)
TABLE 250. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2027 (USD BILLION)
TABLE 251. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 252. GLOBAL CONJUGATE VACCINE MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 253. GLOBAL CONJUGATE VACCINE MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 254. GLOBAL CONJUGATE VACCINE MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 255. GLOBAL CONJUGATE VACCINE MARKET RANKING, BY KEY PLAYER, 2021
TABLE 256. GLOBAL CONJUGATE VACCINE MARKET SHARE, BY KEY PLAYER, 2021
TABLE 257. GLOBAL CONJUGATE VACCINE MARKET MERGER & ACQUISITION
TABLE 258. GLOBAL CONJUGATE VACCINE MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 259. GLOBAL CONJUGATE VACCINE MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 260. GLOBAL CONJUGATE VACCINE MARKET INVESTMENT & FUNDING
TABLE 261. GLOBAL CONJUGATE VACCINE MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 262. GLOBAL CONJUGATE VACCINE MARKET: LICENSE & PRICING

Companies Mentioned

  • Bharat Biotech
  • Biological E. Ltd
  • CSL Limited
  • GlaxoSmithKline, plc.
  • Merck and Company
  • Novartis AG
  • Nuron Biotech Inc.
  • Pfizer, Inc.
  • Sanofi Pasteur
  • Serum Institute of India

Methodology

Loading
LOADING...